James A. Schoeneck - 20 Mar 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Michael Hom, Attorney-in-Fact
Issuer symbol
FGEN
Transactions as of
20 Mar 2025
Net transactions value
+$105,040
Form type
4
Filing time
24 Mar 2025, 09:00:05 UTC
Previous filing
15 Oct 2024
Next filing
06 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Purchase $88,000 +250,000 +339% $0.3520 323,722 20 Mar 2025 By Trust F1
transaction FGEN Common Stock Purchase $17,040 +50,000 +15% $0.3408 373,722 21 Mar 2025 By Trust F2
holding FGEN Common Stock 28,766 20 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3499 to $0.3593. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3341 to $0.3466. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.